Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: Alfredo Nova who wrote (742)	7/16/1998 4:18:00 PM
From: Maxer	Read Replies (1) \| Respond to of 965

This stock goes up and down and it doesn't seem to have very much to do with anything. Friends have made fortunes with it. Timing is everything, cause this one doesn't seem to have a long term growth. Check out a chart (100 day button below). Looks like the back of a stegasorus.

To: Alfredo Nova who wrote (742)	7/16/1998 10:03:00 PM
From: Wilfredo Pagani	Read Replies (1) \| Respond to of 965

Alfredo Avakine will be a good treatment for complicated crohns. So far tnf blockage had not been aproved for UC.As far as Rheumatoid arthritis the immunex people had another anti tnf called Embrel that should be aproved soon to be market by AHP.Both medicine suffer the same problem $$$$$ These tx may be so expensive it will be use only on the more severe cases.Centocor had reopro apparently getting some pressure from CORR new product integrilin ( today more than 2 up ) on the long run I like the activity of CNTO and is adequately value. Saludos Wilfredo